Translating the Combination of Gene Therapy and Tissue Engineering for Treating Recessive Dystrophic Epidermolysis Bullosa

doi 10.22203/ecm.v035a06
Full Text
Abstract

Available in full text

Date
Authors
Publisher

ECM Research Journal

Related search

Recessive Dystrophic Epidermolysis Bullosa Inversa

2020English

Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis Bullosa

New England Journal of Medicine
Medicine
2010English

Safety and Early Efficacy Outcomes for Lentiviral Fibroblast Gene Therapy in Recessive Dystrophic Epidermolysis Bullosa

JCI insight
Medicine
2019English

Mesenchymal Stem Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa: Prospects and Clinical Progress

Expert Opinion on Orphan Drugs
ToxicologyPharmaceuticsPharmacologyHealth Policy
2016English

Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa Using a Self-Inactivating COL7A1 Retroviral Vector

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

1021 Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa Patients Harboring Nonsense Mutations

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Exclusion of Linkage Between the Collagenase Gene and Generalized Recessive Dystrophic Epidermolysis Bullosa Phenotype.

Journal of Clinical Investigation
Medicine
1991English

Image Gallery: Multiple Localized Lipoatrophy in Recessive Dystrophic Epidermolysis Bullosa

British Journal of Dermatology
DermatologyMedicine
2019English

Novel and Emerging Therapies in the Treatment of Recessive Dystrophic Epidermolysis Bullosa

Intractable and Rare Diseases Research
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy